BIO Supports Efforts to Modernize Biotech Reg Process

Regulation System Must Encourage – not Hinder – Innovation Washington, D.C. (July 2, 2015) – The Biotechnology Industry Organization (BIO) welcomes the release of a White House memo regarding the regulation of biotechnology-derived products.

DoD Medical Countermeasure Systems Industry Day

On June 15, 2015, the Department of Defense's (DoD's) Joint Project Manager-Medical Countermeasure Systems (JPM-MCS) held a co-located Industry Day in conjunction with the BIO Convention in Philadelphia, Pennsylvania. The MCS Industry Day focused on industry feedback related to the DoD's proposed use of an Other Transaction Authority (OTA) contracting mechanism. 

Joint Statement from AAU, APLU, BIO, IA, MDMA, NSBA, NVCA, PhRMA, SBTC and USIJ on H.R. 9

We stand united in our continued opposition to H.R. 9, the Innovation Act, as it is currently drafted.

Innovation in Renewable Chemical Platforms to be Highlighted at 2015 BIO World Congress on Industrial Biotechnology

America's renewable chemical and biobased manufacturing industry generated 4 million jobs and contributed $369 billion to the U.S. economy in 2013 alone, according to a recently issued USDA report. The Biotechnology Industry Organization (BIO) is pleased to announce that breakout sessions at the 2015 World Congress on Industrial Biotechnology will feature experts and executives who will showcase the latest innovations, remark on the future of renewable chemicals, and the biobased industry, and highlight how companies and innovators are working to shift towards a bioeconomy. This year’s BIO World Congress on Industrial Biotechnology will be held July 19-22, 2015 at the Palais des congrès de Montréal in Montréal, Canada

Farm Bill Energy Program Rules Will Help Support New Renewable Chemical Manufacturers, BIO Says

The Biotechnology Industry Organization (BIO) today applauded the U.S. Department of Agriculture’s release of new interim final rules for the Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program (“9003 Program”).

BIO and PhRMA Submit Joint Comments to FDA on the Interim Assessment of the NME Review Program

The Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Industry Organization (BIO) submit these comments in response to the Federal Register notice entitled “Interim Assessment of the Program for Enhanced Review Transparency and Communication; Public Meeting and Establishment of Docket” issued by the U.S. Food and Drug Administration (FDA).

Texas Governor Abbott Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

Governor Greg Abbott for signed critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

Bayan Takizawa, Chief Business Officer of ContinuUs, at BIO 2015

Bayan Takizawa on how integrated continuous manufacturing (ICM) has reduced cost and environmental impact, while improving quality assurance for ContinuUs.

2015 BIO International Convention Wednesday Recap

BIO 2015 highlights from Wednesday included keynotes by Dr. Eric Topol and Wynton Marsalis, an interview with NASA astronaut Scott Kelly, and the evening reception at Reading Terminal Market.

Razwin Sulairee, CEO of Malaysian Biotechnology Corporation, at BIO 2015

Razwin Sulairee discuss Malaysia's goal of becoming a player in the global biotechnology industry, and the growth of biotech in the greater Asian region.